Product NDC: | 63739-459 |
Proprietary Name: | Procainamide Hydrochloride |
Non Proprietary Name: | Procainamide Hydrochloride |
Active Ingredient(s): | 100 mg/mL & nbsp; Procainamide Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-459 |
Labeler Name: | McKesson Packaging Services Business Unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089069 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100201 |
Package NDC: | 63739-459-05 |
Package Description: | 5 BAG in 1 BOX (63739-459-05) > 1 VIAL, MULTI-DOSE in 1 BAG > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 63739-459-05 |
Proprietary Name | Procainamide Hydrochloride |
Package Description | 5 BAG in 1 BOX (63739-459-05) > 1 VIAL, MULTI-DOSE in 1 BAG > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 63739-459 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Procainamide Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100201 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Packaging Services Business Unit of McKesson Corporation |
Substance Name | PROCAINAMIDE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antiarrhythmic [EPC] |